Gene Expression Signature Differentiates Histology But Not Progression Status of Early-Stage NSCLC()

Advances in molecular analyses based on high-throughput technologies can contribute to a more accurate classification of non–small cell lung cancer (NSCLC), as well as a better prediction of both the disease course and the efficacy of targeted therapies. Here we set out to analyze whether global gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Charkiewicz, Radoslaw, Niklinski, Jacek, Claesen, Jürgen, Sulewska, Anetta, Kozlowski, Miroslaw, Michalska-Falkowska, Anna, Reszec, Joanna, Moniuszko, Marcin, Naumnik, Wojciech, Niklinska, Wieslawa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2017
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408153/
https://www.ncbi.nlm.nih.gov/pubmed/28456114
http://dx.doi.org/10.1016/j.tranon.2017.01.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408153/
https://www.ncbi.nlm.nih.gov/pubmed/28456114
http://dx.doi.org/10.1016/j.tranon.2017.01.015

Ejemplares similares